Cargando…
PB2324: SAFE ADMINISTRATION OF SECOND DOSE OF MRNA COVID-19 VACCINE FOLLOWING DEVELOPMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431490/ http://dx.doi.org/10.1097/01.HS9.0000852120.42895.8a |
_version_ | 1784780069641650176 |
---|---|
author | Hajizadeh Barfejani, A. Prasad, S. Henry, D. |
author_facet | Hajizadeh Barfejani, A. Prasad, S. Henry, D. |
author_sort | Hajizadeh Barfejani, A. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9431490 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-94314902022-08-31 PB2324: SAFE ADMINISTRATION OF SECOND DOSE OF MRNA COVID-19 VACCINE FOLLOWING DEVELOPMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA Hajizadeh Barfejani, A. Prasad, S. Henry, D. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431490/ http://dx.doi.org/10.1097/01.HS9.0000852120.42895.8a Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Publication Only Hajizadeh Barfejani, A. Prasad, S. Henry, D. PB2324: SAFE ADMINISTRATION OF SECOND DOSE OF MRNA COVID-19 VACCINE FOLLOWING DEVELOPMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA |
title | PB2324: SAFE ADMINISTRATION OF SECOND DOSE OF MRNA COVID-19 VACCINE FOLLOWING DEVELOPMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA |
title_full | PB2324: SAFE ADMINISTRATION OF SECOND DOSE OF MRNA COVID-19 VACCINE FOLLOWING DEVELOPMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA |
title_fullStr | PB2324: SAFE ADMINISTRATION OF SECOND DOSE OF MRNA COVID-19 VACCINE FOLLOWING DEVELOPMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA |
title_full_unstemmed | PB2324: SAFE ADMINISTRATION OF SECOND DOSE OF MRNA COVID-19 VACCINE FOLLOWING DEVELOPMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA |
title_short | PB2324: SAFE ADMINISTRATION OF SECOND DOSE OF MRNA COVID-19 VACCINE FOLLOWING DEVELOPMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA |
title_sort | pb2324: safe administration of second dose of mrna covid-19 vaccine following development of idiopathic thrombocytopenic purpura |
topic | Publication Only |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431490/ http://dx.doi.org/10.1097/01.HS9.0000852120.42895.8a |
work_keys_str_mv | AT hajizadehbarfejania pb2324safeadministrationofseconddoseofmrnacovid19vaccinefollowingdevelopmentofidiopathicthrombocytopenicpurpura AT prasads pb2324safeadministrationofseconddoseofmrnacovid19vaccinefollowingdevelopmentofidiopathicthrombocytopenicpurpura AT henryd pb2324safeadministrationofseconddoseofmrnacovid19vaccinefollowingdevelopmentofidiopathicthrombocytopenicpurpura |